US Patent RE39485 Oral Glutamine to reduce stomatitis
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Keith M. Skubitz0
Peter M. Anderson0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+263 characters)
Article
Patent abstract
Glutamine is administered orally at a rate of about 4.5 g/m2 per day to treat oropharyngeal mucositis. This is administered to patients that experience or may develop oropharyngeal mucositis, especially those caused by chemotherapy or radiotherapy.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent RE039485 Oral Glutamine to reduce stomatitis US Patent RE39485 Oral Glutamine to reduce stomatitis
Infobox
Patent Number
RE0394850
Patent Number
RE394850
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
RE0394850
Date of Patent
February 6, 2007
0Patent Application Number
108478100
Date Filed
May 18, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent RE039485 Oral Glutamine to reduce stomatitis
Infobox
Is a
Patent jurisdiction
Patent number
RE039485
Date of patent
February 6, 2007
Patent application number
10847810
Date Filed
May 18, 2004
Patent primary examiner
Find more entities like US Patent RE39485 Oral Glutamine to reduce stomatitis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
